{{Rsnum
|rsid=353639
|Gene=CD44
|Chromosome=11
|position=35162817
|Orientation=minus
|GMAF=0.2957
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 57.5 | 37.2 | 5.3
| HCB | 72.8 | 26.5 | 0.7
| JPT | 71.7 | 27.4 | 0.9
| YRI | 16.3 | 44.9 | 38.8
| ASW | 29.8 | 49.1 | 21.1
| CHB | 72.8 | 26.5 | 0.7
| CHD | 75.2 | 23.9 | 0.9
| GIH | 66.3 | 25.7 | 7.9
| LWK | 16.7 | 56.5 | 26.9
| MEX | 46.6 | 43.1 | 10.3
| MKK | 43.9 | 45.8 | 10.3
| TSI | 73.5 | 21.6 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23940692
|Title=CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population
|OA=1
}}

{{PMID Auto
|PMID=17903303
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=25009318
|Title=Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}